Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Radiology
    April 2024
  1. YOON JH, Kim YK, Kim JW, Chang W, et al
    Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
    Radiology. 2024;311:e233114.
    >> Share

  2. LEE Y, Kim NH, Kang JH, Cho YS, et al
    Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
    Radiology. 2024;311:e232188.
    >> Share

  3. LYU L, Xu P
    Hepatic CT Perfusion in Budd-Chiari Syndrome before and after Intervention.
    Radiology. 2024;311:e232426.
    >> Share

  4. GHOSH A
    B-mode US and Deep Learning Rivals Shear-Wave Elastography in Screening for Fibrosis.
    Radiology. 2024;311:e240868.
    >> Share

  5. ZENG QQ, Liang P
    Super-Resolution US Imaging of Focal Nodular Hyperplasia.
    Radiology. 2024;311:e233130.
    >> Share

  6. CHEN LD, Huang ZR, Yang H, Cheng MQ, et al
    US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening.
    Radiology. 2024;311:e231461.
    >> Share

    March 2024
  7. MOURA CUNHA G, Fan B, Navin PJ, Olivie D, et al
    Interpretation, Reporting, and Clinical Applications of Liver MR Elastography.
    Radiology. 2024;310:e231220.
    >> Share

  8. LIU F, Bi M, Jing X, Ding H, et al
    Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
    Radiology. 2024;310:e232416.
    >> Share

  9. REUTER KL
    Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
    Radiology. 2024;310:e240436.
    >> Share

    February 2024
  10. CHAPIRO J
    Image-guided High-Dose-Rate Brachytherapy for Hepatocellular Carcinoma Could Be the Ultimate Ablation Tool.
    Radiology. 2024;310:e240072.
    >> Share

  11. AUER TA, Muller L, Schulze D, Anhamm M, et al
    CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
    Radiology. 2024;310:e232044.
    >> Share

  12. SHEWAREGA A, Santana JG, Nam D, Berz A, et al
    Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8(+) T-Cell Infiltration in Murine Hepatocellular Carcinoma.
    Radiology. 2024;310:e232365.
    >> Share

  13. GEMMETE JJ
    Partial Cryoablation and Matrix Metalloproteinase Inhibition May Be a Possible Treatment Option for Hepatocellular Carcinoma.
    Radiology. 2024;310:e240015.
    >> Share

  14. CRIVELLARO P
    A Deeper Look into Ancillary Features in LI-RADS Classification.
    Radiology. 2024;310:e240251.
    >> Share

  15. DAWIT H, Lam E, McInnes MDF, van der Pol CB, et al
    LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma and Malignancy: An Individual Participant Data Meta-Analysis.
    Radiology. 2024;310:e231501.
    >> Share

  16. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
    Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
    Radiology. 2024;310:e231160.
    >> Share

  17. KARTALIS N, Grigoriadis A
    LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
    Radiology. 2024;310:e240161.
    >> Share

    January 2024
  18. MA L, Zhang W, Ma J, Luo J, et al
    Transjugular Intrahepatic Portosystemic Shunt versus Endoscopy with Drug Therapy Warrants Further Exploration.
    Radiology. 2024;310:e232499.
    >> Share

  19. TAN XZ, Chen X, Liu P
    Potential Influence of Inconsistent Arterial Phase Imaging on Macrotrabecular-massive Hepatocellular Carcinoma Prediction.
    Radiology. 2024;310:e232349.
    >> Share

  20. KADI D, Loomba R, Bashir MR
    Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions.
    Radiology. 2024;310:e222695.
    >> Share

  21. FOWLER KJ, Chernyak V
    What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease.
    Radiology. 2024;310:e232771.
    >> Share

  22. DIETRICH CF
    Modified Algorithm for Contrast-enhanced US LI-RADS.
    Radiology. 2024;310:e232742.
    >> Share

    December 2023
  23. GOINS SM, Jiang H, van der Pol CB, Salameh JP, et al
    Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis.
    Radiology. 2023;309:e231656.
    >> Share

  24. SIRLIN CB, Chernyak V
    Are We Ready to Simplify and Improve LI-RADS?
    Radiology. 2023;309:e233164.
    >> Share

  25. TAMIR S, Tau N
    Hepatocellular Carcinoma and Pretransplant Liver Imaging: Benefits of Per-patient Assessment.
    Radiology. 2023;309:e233123.
    >> Share

  26. HASSAN OT, Behr SC, Ohliger MA, Fowler KJ, et al
    Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222776.
    >> Share

    November 2023
  27. JIANG H, Yang C, Chen Y, Wang Y, et al
    Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
    Radiology. 2023;309:e230527.
    >> Share

  28. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
    Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222891.
    >> Share

  29. TSAI R, Mellnick VM
    Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
    Radiology. 2023;309:e232480.
    >> Share

  30. OZTURK A, Kumar V, Pierce TT, Li Q, et al
    The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
    Radiology. 2023;309:e223146.
    >> Share

  31. TAN XZ, Liu P, Xiang H
    The Influence of Single Arterial Phase Imaging on Prediction of Microvascular Invasion of Hepatocellular Carcinoma.
    Radiology. 2023;309:e231141.
    >> Share

    October 2023
  32. TUTHILL TA
    Advancing AI-assisted US Screening for Fatty Liver.
    Radiology. 2023;309:e232442.
    >> Share

  33. HAN A
    Hepatic Steatosis Assessment: Harnessing the Power of Integrating Multiple Quantitative US Parameters.
    Radiology. 2023;309:e232475.
    >> Share

  34. VIANNA P, Calce SI, Boustros P, Larocque-Rigney C, et al
    Comparison of Radiologists and Deep Learning for US Grading of Hepatic Steatosis.
    Radiology. 2023;309:e230659.
    >> Share

  35. KURODA H, Oguri T, Kamiyama N, Toyoda H, et al
    Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
    Radiology. 2023;309:e230341.
    >> Share

  36. SAVSANI E, Shaw CM, Forsberg F, Wessner CE, et al
    Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
    Radiology. 2023;309:e230727.
    >> Share

  37. HEO S, Lee SS, Choi SH, Kim DW, et al
    CT Rule-in and Rule-out Criteria for Clinically Significant Portal Hypertension in Chronic Liver Disease.
    Radiology. 2023;309:e231208.
    >> Share

  38. FRAUM TJ
    CT-based Diagnosis of Clinically Significant Portal Hypertension: An Opportunity to Prevent Complications.
    Radiology. 2023;309:e232439.
    >> Share

  39. XIA T, Du M, Li H, Wang Y, et al
    Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
    Radiology. 2023;309:e231007.
    >> Share

  40. REEDER SB, Starekova J
    MRI Proton Density Fat Fraction for Liver Disease Risk Assessment: A Call for Clinical Implementation.
    Radiology. 2023;309:e232552.
    >> Share

  41. MONSELL SE
    Statistical Methods for Exploring Causal Relationships between Risk Factors and Liver Disease.
    Radiology. 2023;309:e232551.
    >> Share

  42. FOWLER KJ, Venkatesh SK, Obuchowski N, Middleton MS, et al
    Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
    Radiology. 2023;309:e231092.
    >> Share

  43. KOZAKA K, Matsui O
    MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease.
    Radiology. 2023;309:e232420.
    >> Share

    September 2023
  44. HYODO R, Takehara Y, Mizuno T, Ichikawa K, et al
    Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization.
    Radiology. 2023;308:e230709.
    >> Share

    August 2023
  45. LI X, Zhang Y, Wang X, Zeng H, et al
    Predicting Infectious Complications after Percutaneous Thermal Ablation of Liver Malignancies: A 12-year Single-Center Experience.
    Radiology. 2023;308:e223091.
    >> Share

  46. BEN-ARIE G, Sosna J
    Predicting Infectious Complications after US-guided Ablation of Liver Malignancies: Personalized Patient Care.
    Radiology. 2023;308:e231681.
    >> Share

  47. LI J, Liu G, Xie X, Zhang D, et al
    Outcomes Following Different Thermal Ablation Strategies in Patients with Unresectable Colorectal Liver Metastases.
    Radiology. 2023;308:e223135.
    >> Share

  48. GEORGIADES CS
    Combination Systemic Chemotherapy and Ablation Treatment for Potentially Curable Patients with Colorectal Liver Metastases: Ablate Completely and Ablate Early.
    Radiology. 2023;308:e231709.
    >> Share

  49. LI M, Fan Y, You H, Li C, et al
    Dual-Energy CT Deep Learning Radiomics to Predict Macrotrabecular-Massive Hepatocellular Carcinoma.
    Radiology. 2023;308:e230255.
    >> Share

  50. WANG X, Liu G, Wu J, Xiao X, et al
    Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis.
    Radiology. 2023;308:e223201.
    >> Share

  51. CHU LC, Fishman EK
    AI as Virtual Biopsy Tool to Predict Macrotrabecular-Massive Hepatocellular Carcinoma.
    Radiology. 2023;308:e231663.
    >> Share

  52. BARTH KH
    Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation, an Unequal Competition.
    Radiology. 2023;308:e231774.
    >> Share

  53. LI L, Zou X, Zheng W, Li Y, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma.
    Radiology. 2023;308:e230150.
    >> Share

  54. BAO Y, Li JX, Zhou P, Tong Y, et al
    Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization.
    Radiology. 2023;308:e230457.
    >> Share

  55. KIM TK
    Contrast-enhanced US Incorporating Kupffer-Phase Findings for the Diagnosis of Hepatocellular Carcinoma.
    Radiology. 2023;308:e231494.
    >> Share

    July 2023
  56. WANG C, Huang Y, Liu C, Liu F, et al
    Erratum for: Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
    Radiology. 2023;308:e239019.
    >> Share

    June 2023
  57. BARR RG, Scoutt LM
    Screening for Hepatocellular Carcinoma:Image Quality Is Everything!
    Radiology. 2023;307:e231089.
    >> Share

  58. PARK MK, Lee DH, Hur BY, Lee HC, et al
    Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
    Radiology. 2023;307:e222106.
    >> Share

  59. HONG CW, Chernyak V, Choi JY, Lee S, et al
    A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT.
    Radiology. 2023;307:e222855.
    >> Share

  60. JOHNSON SA
    Reliability of LI-RADS for MRI and CT: Is Excellence Achievable?
    Radiology. 2023;307:e231066.
    >> Share

  61. GALGANO SJ, Smith EN
    LI-RADS Version 2018 for MRI and CT: Interreader Agreement in Real-World Practice.
    Radiology. 2023;307:e231212.
    >> Share

    May 2023
  62. PENG D, Cao J, Guo C, He J, et al
    Influence of Cirrhosis on (68)Ga-FAPI PET/CT in Intrahepatic Tumors.
    Radiology. 2023 May 23:222448. doi: 10.1148/radiol.222448.
    >> Share

  63. NACHIT M, Horsmans Y, Summers RM, Leclercq IA, et al
    AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
    Radiology. 2023 May 16:222008. doi: 10.1148/radiol.222008.
    >> Share

  64. GOINS SM, Adamo RG, Lam E, Costa AF, et al
    Conversion Strategy for LI-RADS Category 5 Observations across Versions 2014, 2017, and 2018.
    Radiology. 2023;307:e222971.
    >> Share

    April 2023
  65. XIA TY, Zhou ZH, Meng XP, Zha JH, et al
    Predicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model.
    Radiology. 2023 Apr 25:222729. doi: 10.1148/radiol.222729.
    >> Share

  66. SUMMERS RM
    Radiomics to Predict Microvascular Invasion in Hepatocellular Carcinoma: A Promising Biomarker for Tumor Recurrence.
    Radiology. 2023 Apr 25:230657. doi: 10.1148/radiol.230657.
    >> Share

  67. FOWLER KJ, Chernyak V, Ronot M, Vilgrain V, et al
    Hepatocellular Carcinoma: It Is Time to Focus on Prognosis.
    Radiology. 2023 Apr 4:220884. doi: 10.1148/radiol.220884.
    >> Share

  68. RONOT M, Chernyak V, Burgoyne A, Chang J, et al
    Imaging to Predict Prognosis in Hepatocellular Carcinoma: Current and Future Perspectives.
    Radiology. 2023 Apr 4:221429. doi: 10.1148/radiol.221429.
    >> Share

  69. CHERNYAK V, Fowler KJ, Do RKG, Kamaya A, et al
    LI-RADS: Looking Back, Looking Forward.
    Radiology. 2023;307:e222801.
    >> Share

  70. FERRAIOLI G, Barr RG
    Interpreting Liver Stiffness Values in Clinical Practice: Is Histologic Classification Necessary for Clinical Relevance?
    Radiology. 2023;307:e220553.
    >> Share

  71. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2023;307:e239005.
    >> Share

    March 2023
  72. GRANT EG
    Calibrated US for Quantification of Fatty Liver Disease.
    Radiology. 2023;306:e221540.
    >> Share

  73. SUGIMOTO K, Lee DH, Itoi T
    Response to "Limitations of a Multiparametric US Score for NASH Prediction".
    Radiology. 2023;306:e221498.
    >> Share

    February 2023
  74. YEOM A, Chi SA, Song KD
    Added Value of Pelvic CT after Treatment of HCC.
    Radiology. 2023 Feb 21:222314. doi: 10.1148/radiol.222314.
    >> Share

  75. JIANG H, Wei H, Yang T, Qin Y, et al
    VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
    Radiology. 2023 Feb 14:221835. doi: 10.1148/radiol.221835.
    >> Share

  76. HARMATH CB
    Beyond LI-RADS: Decoding the Prognostic Value of MRI Findings in HCC.
    Radiology. 2023 Feb 14:223309. doi: 10.1148/radiol.223309.
    >> Share

    January 2023
  77. ROLDAN-ALZATE A, Reeder SB
    Image-based Vascular Modeling for Portal Hypertension Diagnosis.
    Radiology. 2023 Jan 31:223163. doi: 10.1148/radiol.223163.
    >> Share

  78. WANG C, Huang Y, Liu C, Liu F, et al
    Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
    Radiology. 2023 Jan 31:221648. doi: 10.1148/radiol.221648.
    >> Share

  79. SOFOCLEOUS CT
    Automated Segmentation of CT-guided Ablation Margins in Colorectal Liver Metastases: How We Move Forward to a Standardization of Ablation Zone Assessment.
    Radiology. 2023 Jan 31:223276. doi: 10.1148/radiol.223276.
    >> Share

  80. LIN YM, Paolucci I, O'Connor CS, Anderson BM, et al
    Ablative Margins of Colorectal Liver Metastases Using Deformable CT Image Registration and Autosegmentation.
    Radiology. 2023 Jan 31:221373. doi: 10.1148/radiol.221373.
    >> Share

  81. KIM H
    The Feasibility of Abbreviated MRI for Active Surveillance of Hepatocellular Carcinoma.
    Radiology. 2023 Jan 24:223113. doi: 10.1148/radiol.223113.
    >> Share

  82. YOKOO T, Masaki N, Parikh ND, Lane BF, et al
    Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.
    Radiology. 2023 Jan 24:220917. doi: 10.1148/radiol.220917.
    >> Share

  83. LEE S, Kim YY, Shin J, Son WJ, et al
    Percentages of Hepatocellular Carcinoma in LI-RADS Categories with CT and MRI: A Systematic Review and Meta-Analysis.
    Radiology. 2023 Jan 10:220646. doi: 10.1148/radiol.220646.
    >> Share

  84. RONOT M
    Is MRI Better than CT for the LI-RADS?
    Radiology. 2023 Jan 10:222755. doi: 10.1148/radiol.222755.
    >> Share

  85. SIDHU PS, Fang C
    US-based Hepatic Fat Quantification: An Emerging Technique and Game Changer?
    Radiology. 2023 Jan 3:223002. doi: 10.1148/radiol.223002.
    >> Share

  86. JEON SK, Lee JM, Joo I, Yoon JH, et al
    Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.
    Radiology. 2023 Jan 3:221510. doi: 10.1148/radiol.221510.
    >> Share

  87. FUJITA S, Sano K, Cruz G, Fukumura Y, et al
    MR Fingerprinting for Liver Tissue Characterization: A Histopathologic Correlation Study.
    Radiology. 2023;306:150-159.
    >> Share

    December 2022
  88. YOON JH, Kim H
    CT Radiomics in Oncology: Insights into the Tumor Microenvironment of Hepatocellular Carcinoma.
    Radiology. 2022 Dec 13:222988. doi: 10.1148/radiol.222988.
    >> Share

  89. FENG Z, Li H, Liu Q, Duan J, et al
    CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
    Radiology. 2022 Dec 13:221291. doi: 10.1148/radiol.221291.
    >> Share

  90. SENDUR HN, Cerit MN
    Reliable Assessment of US Performance for Liver Fat Quantification.
    Radiology. 2022;305:E70.
    >> Share

  91. WU W, Jing X, Xue GQ, Zhu XL, et al
    A Multicenter Randomized Controlled Study of Contrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions.
    Radiology. 2022;305:721-728.
    >> Share

  92. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022;305:E73.
    >> Share

    November 2022
  93. ZHANG W, Huang C, Yin T, Miao X, et al
    Ultrasensitive US Microvessel Imaging of Hepatic Microcirculation in the Cirrhotic Rat Liver.
    Radiology. 2022 Nov 22:220739. doi: 10.1148/radiol.220739.
    >> Share

  94. FETZER DT
    US Microvessel Imaging of Rat Liver Microcirculation: Opportunities and Challenges for Human Imaging.
    Radiology. 2022 Nov 22:222735. doi: 10.1148/radiol.222735.
    >> Share

  95. FETZER DT, Rosado-Mendez IM, Wang M, Robbin ML, et al
    Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization.
    Radiology. 2022;305:265-276.
    >> Share

  96. YOON JH
    A Placebo Effect on MRI Proton Density Fat Fraction in Nonalcoholic Steatohepatitis Trials.
    Radiology. 2022 Nov 1:222295. doi: 10.1148/radiol.222295.
    >> Share

  97. NEDRUD MA, Chaudhry M, Middleton MS, Moylan CA, et al
    MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials.
    Radiology. 2022 Nov 1:220743. doi: 10.1148/radiol.220743.
    >> Share

    October 2022
  98. WEIJERS G, Munsterman ID, Thijssen JM, Kuppeveld H, et al
    Noninvasive Staging of Hepatic Steatosis Using Calibrated 2D US with Liver Biopsy as the Reference Standard.
    Radiology. 2022 Oct 18:220104. doi: 10.1148/radiol.220104.
    >> Share

  99. WEAR KA, Han A, Rubin JM, Gao J, et al
    US Backscatter for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Radiology. 2022 Oct 18:220606. doi: 10.1148/radiol.220606.
    >> Share

  100. KITAO A, Matsui O, Zhang Y, Ogi T, et al
    Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
    Radiology. 2022 Oct 11:220531. doi: 10.1148/radiol.220531.
    >> Share

  101. HSIEH SS, Cook DA, Inoue A, Gong H, et al
    Understanding Reader Variability: A 25-Radiologist Study on Liver Metastasis Detection at CT.
    Radiology. 2022 Oct 4:220266. doi: 10.1148/radiol.220266.
    >> Share

  102. EMMONS EC, Bishay S, Du L, Krebs H, et al
    Survival and Toxicities after (90)Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry.
    Radiology. 2022;305:228-236.
    >> Share

    September 2022
  103. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022 Sep 27:221149. doi: 10.1148/radiol.221149.
    >> Share

  104. GHELFI J, Decaens T, Macek Jilkova Z
    Rat Model of Hepatocellular Carcinoma for Better Understanding Immune Effects of Transarterial Chemoembolization.
    Radiology. 2022 Sep 6:220179. doi: 10.1148/radiol.220179.
    >> Share

  105. VALENCIA SA, Romero JA
    Limitations of a Multiparametric US Score for NASH Prediction.
    Radiology. 2022;304:E50.
    >> Share

    August 2022
  106. XIE J, Wei X
    Cirrhosis-related Spontaneous Mesocaval Shunt.
    Radiology. 2022 Aug 23:220564. doi: 10.1148/radiol.220564.
    >> Share

  107. KWAG M, Choi SH, Choi SJ, Byun JH, et al
    Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI.
    Radiology. 2022 Aug 16:220659. doi: 10.1148/radiol.220659.
    >> Share

  108. DEIPOLYI AR, Johnson CB, Riedl CC, Kunin H, et al
    Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis.
    Radiology. 2022 Aug 16:220158. doi: 10.1148/radiol.220158.
    >> Share

  109. CHOI SJ, Lee SS, Jung KH, Lee JB, et al
    Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
    Radiology. 2022 Aug 9:220536. doi: 10.1148/radiol.220536.
    >> Share

  110. LUQUE-CABAL M, Alvarez-Guisasola V, Rizzo-Raza S, Sales-Fernandez C, et al
    Case 304: Porphyria Cutanea Tarda.
    Radiology. 2022;304:488-492.
    >> Share

  111. TORKIAN P, Akhlaghpoor S
    Considerations Regarding Image-guided Treatment of Liver Hemangioma.
    Radiology. 2022;304:E45.
    >> Share

  112. YAN Y
    Three-dimensional MR Elastography in Distinguishing Necroinflammation from Liver Fibrosis.
    Radiology. 2022;304:E43.
    >> Share

  113. BARR RG
    US-targeted Microbubbles to Assess Liver Fibrosis.
    Radiology. 2022;304:483-484.
    >> Share

    July 2022
  114. DUBINSKY TJ
    Evaluating Hepatic Steatosis with MRI as the Reference Standard: Different Performances of Three US Machines.
    Radiology. 2022 Jul 12:221177. doi: 10.1148/radiol.221177.
    >> Share

  115. CASSINOTTO C, Jacq T, Anselme S, Ursic-Bedoya J, et al
    Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
    Radiology. 2022 Jul 12:212846. doi: 10.1148/radiol.212846.
    >> Share

    June 2022
  116. JANG JK, Lee ES, Seo JW, Kim YR, et al
    Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.
    Radiology. 2022 Jun 21:220220. doi: 10.1148/radiol.220220.
    >> Share

  117. GAO RZ, Sun WB, Gao J
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: Is It a Promising Treatment for Giant Liver Hemangioma?
    Radiology. 2022;303:E39.
    >> Share

  118. RONOT M
    Performance of LI-RADS for the Noninvasive Diagnosis of HCC: Pathology Should Not Be the Only Acceptable Reference.
    Radiology. 2022;303:546-547.
    >> Share

    May 2022
  119. KHANNA G, Alazraki AL
    Quantitative US versus Quantitative MRI in the Assessment of Pediatric Chronic Liver Disease.
    Radiology. 2022 May 24:221066. doi: 10.1148/radiol.221066.
    >> Share

  120. ALVES VPV, Dillman JR, Tkach JA, Bennett PS, et al
    Comparison of Quantitative Liver US and MRI in Patients with Liver Disease.
    Radiology. 2022 May 24:212995. doi: 10.1148/radiol.212995.
    >> Share

  121. RAMAN AG, Jones C, Weiss CR
    Machine Learning for Hepatocellular Carcinoma Segmentation at MRI: Radiology In Training.
    Radiology. 2022 May 10:212386. doi: 10.1148/radiol.212386.
    >> Share

  122. MIAO X, Sha T, Zhang W, Zhou H, et al
    Liver Fibrosis Assessment by Viewing Sinusoidal Capillarization: US Molecular Imaging versus Two-dimensional Shear-Wave Elastography in Rats.
    Radiology. 2022 May 3:212325. doi: 10.1148/radiol.212325.
    >> Share

    April 2022
  123. BORDE T, Nezami N, Gaupp FL, Savic LJ, et al
    Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.
    Radiology. 2022 Apr 12:212426. doi: 10.1148/radiol.212426.
    >> Share

  124. WHITE SB
    The Immune Response: A New Frontier in Interventional Oncology.
    Radiology. 2022;303:229-230.
    >> Share

  125. ATRI M, Jang HJ, Kim TK, Khalili K, et al
    Contrast-enhanced US of the Liver and Kidney: A Problem-solving Modality.
    Radiology. 2022;303:11-25.
    >> Share

  126. KENNEDY P, Marron TU, Taouli B
    Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?
    Radiology. 2022;303:226-228.
    >> Share

    March 2022
  127. ITO K
    US-derived Fat Fraction Screening of Hepatic Steatosis.
    Radiology. 2022 Mar 29:213052. doi: 10.1148/radiol.213052.
    >> Share

  128. JUNG J, Han A, Madamba E, Bettencourt R, et al
    Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
    Radiology. 2022 Mar 29:211131. doi: 10.1148/radiol.211131.
    >> Share

  129. LEE JT
    Sarcopenia at Abdominal CT in Patients with Cirrhosis.
    Radiology. 2022 Mar 15:220191. doi: 10.1148/radiol.220191.
    >> Share

  130. ZAFAR F, Lubert AM, Trout AT, Katz DA, et al
    Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation.
    Radiology. 2022 Mar 15:211037. doi: 10.1148/radiol.211037.
    >> Share

  131. LIU J, Ma J, Yang C, Chen M, et al
    Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
    Radiology. 2022 Mar 15:211172. doi: 10.1148/radiol.211172.
    >> Share

  132. DHONDT E, Lambert B, Hermie L, Huyck L, et al
    (90)Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial.
    Radiology. 2022 Mar 8:211806. doi: 10.1148/radiol.211806.
    >> Share

  133. VAN DER POL CB, McInnes MDF, Salameh JP, Chernyak V, et al
    Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
    Radiology. 2022 Mar 1:212340. doi: 10.1148/radiol.212340.
    >> Share

  134. DUAN L, Zhang BH, Zheng XH
    No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma.
    Radiology. 2022 Mar 1:211994. doi: 10.1148/radiol.211994.
    >> Share

    February 2022
  135. CHUNG JW
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of New Systemic Agents.
    Radiology. 2022 Feb 1:212826. doi: 10.1148/radiol.212826.
    >> Share

  136. ZHENG K, Zhu X, Fu S, Cao G, et al
    Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
    Radiology. 2022 Feb 1:211545. doi: 10.1148/radiol.211545.
    >> Share

    January 2022
  137. FERRAIOLI G, Kumar V, Ozturk A, Nam K, et al
    US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Radiology. 2022 Jan 25:210736. doi: 10.1148/radiol.210736.
    >> Share

  138. TISCHFIELD DJ, Gurevich A, Johnson O, Gatmaytan I, et al
    Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model.
    Radiology. 2022 Jan 11:211028. doi: 10.1148/radiol.211028.
    >> Share

  139. JENSEN CT, Gupta S, Saleh MM, Liu X, et al
    Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.
    Radiology. 2022 Jan 11:211838. doi: 10.1148/radiol.211838.
    >> Share

    December 2021
  140. LOCKHART ME
    NASH Diagnosis Made Better but Maybe Not Yet Easier.
    Radiology. 2021;301:635-636.
    >> Share

  141. SUGIMOTO K, Lee DH, Lee JY, Yu SJ, et al
    Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study.
    Radiology. 2021;301:625-634.
    >> Share

    November 2021
  142. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2021 Nov 16:211244. doi: 10.1148/radiol.2021211244.
    >> Share

  143. MARTI-AGUADO D, Jimenez-Pastor A, Alberich-Bayarri A, Rodriguez-Ortega A, et al
    Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Radiology. 2021 Nov 16:211027. doi: 10.1148/radiol.2021211027.
    >> Share

  144. DING PX, Lee EW
    Spontaneous Portosystemic Shunt with Budd-Chiari Syndrome.
    Radiology. 2021;301:282.
    >> Share

  145. AYOOBI YAZDI N, Mehrabinejad MM, Dashti H, Pourghorban R, et al
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
    Radiology. 2021;301:464-471.
    >> Share

    October 2021
  146. PEREZ AA, Noe-Kim V, Lubner MG, Graffy PM, et al
    Deep Learning CT-based Quantitative Visualization Tool for Liver Volume Estimation: Defining Normal and Hepatomegaly.
    Radiology. 2021 Oct 26:210531. doi: 10.1148/radiol.2021210531.
    >> Share

  147. REEDER SB
    Emergence of 3D MR Elastography-based Quantitative Markers for Diffuse Liver Disease.
    Radiology. 2021;301:163-165.
    >> Share

  148. SOULEN MC, Garcia-Monaco R
    Closing the Gap in Curative Ablation of Liver Cancer.
    Radiology. 2021;301:237-238.
    >> Share

    September 2021
  149. MORRELL GR
    Detection of Tumor Thrombus in Hepatocellular Carcinoma.
    Radiology. 2021 Sep 28:211984. doi: 10.1148/radiol.2021211984.
    >> Share

  150. BAE JS, Lee JM, Jeon SK, Yoo J, et al
    LI-RADS Tumor in Vein at CT and Hepatobiliary MRI.
    Radiology. 2021 Sep 28:210215. doi: 10.1148/radiol.2021210215.
    >> Share

  151. YU MM, Tang XL, Jin H, Yang S, et al
    Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.
    Radiology. 2021 Sep 21:210355. doi: 10.1148/radiol.2021210355.
    >> Share

  152. STAREKOVA J, Hernando D, Pickhardt PJ, Reeder SB, et al
    Quantification of Liver Fat Content with CT and MRI: State of the Art.
    Radiology. 2021 Sep 21:204288. doi: 10.1148/radiol.2021204288.
    >> Share

    August 2021
  153. ZHANG T, Zhang G, Deng X, Zeng J, et al
    APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Radiology. 2021 Aug 24:204700. doi: 10.1148/radiol.2021204700.
    >> Share

  154. SHI Y, Qi YF, Lan GY, Wu Q, et al
    Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C.
    Radiology. 2021 Aug 10:202804. doi: 10.1148/radiol.2021202804.
    >> Share

    July 2021
  155. LEE DH, Lee MW, Kim PN, Lee YJ, et al
    Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Radiology. 2021 Jul 27:210309. doi: 10.1148/radiol.2021210309.
    >> Share

  156. HE KS, Fernando R, Cabrera T, Valenti D, et al
    Hepatic Hilar Nerve Block for Hepatic Interventions: Anatomy, Technique, and Initial Clinical Experience in Thermal Ablation of Liver Tumors.
    Radiology. 2021 Jul 13:203410. doi: 10.1148/radiol.2021203410.
    >> Share

  157. KRINSKY G, Shanbhogue K
    Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
    Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.
    >> Share

  158. KANG HJ, Kim H, Lee DH, Hur BY, et al
    Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
    >> Share

    June 2021
  159. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
    Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
    Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
    >> Share

  160. DU J, Bydder GM
    Brain Atrophy Is a Better Biomarker than Susceptibility for Evaluating Clinical Severity in Wilson Disease.
    Radiology. 2021;299:673-674.
    >> Share

    May 2021
  161. BAI XM, Cui M, Yang W, Wang H, et al
    The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
    >> Share

  162. YOON JH, Kim H
    CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.
    Radiology. 2021 May 11:210379. doi: 10.1148/radiol.2021210379.
    >> Share

  163. FENG Z, Li H, Zhao H, Jiang Y, et al
    Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Radiology. 2021 May 11:203614. doi: 10.1148/radiol.2021203614.
    >> Share

  164. MEIJERINK MR, Ruarus AH, Vroomen LGPH, Puijk RS, et al
    Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Radiology. 2021;299:470-480.
    >> Share

    April 2021
  165. PAISANT A, Gillard M, Oberti F, Roux M, et al
    Validation of a Diagnostic Algorithm for Hepatocellular Carcinoma at Gadoxetic Acid-enhanced MRI.
    Radiology. 2021 Apr 27:204529. doi: 10.1148/radiol.2021204529.
    >> Share

  166. LV J, Xu Y, Xu L, Nie L, et al
    Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.
    Radiology. 2021 Apr 27:204134. doi: 10.1148/radiol.2021204134.
    >> Share

  167. LUZ JHM, Veloso Gomes F, Costa NV, Vasco I, et al
    BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils.
    Radiology. 2021 Apr 6:204055. doi: 10.1148/radiol.2021204055.
    >> Share

    March 2021
  168. DUSEK P, Lescinskij A, Ruzicka F, Acosta-Cabronero J, et al
    Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
    Radiology. 2021 Mar 23:202846. doi: 10.1148/radiol.2021202846.
    >> Share

  169. BASHIR MR, Mendiratta-Lala M
    CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
    Radiology. 2021 Mar 2:210049. doi: 10.1148/radiol.2021210049.
    >> Share

    February 2021
  170. REEDER SB
    Portosystemic Shunts: Should We Pay Closer Attention with Cross-Sectional Imaging?
    Radiology. 2021 Feb 2:204282. doi: 10.1148/radiol.2021204282.
    >> Share

    January 2021
  171. HU HH, Yokoo T, Bashir MR, Sirlin CB, et al
    Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study.
    Radiology. 2021 Jan 19:202912. doi: 10.1148/radiol.2021202912.
    >> Share

  172. CHANDARANA H, Shanbhogue K
    Noninvasive Staging of Liver Fibrosis with Dual-Energy CT: Close but No Cigar.
    Radiology. 2021 Jan 5:204315. doi: 10.1148/radiol.2021204315.
    >> Share

  173. MARRI UK, Das P, Shalimar, Kalaivani M, et al
    Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
    Radiology. 2021 Jan 5:202232. doi: 10.1148/radiol.2021202232.
    >> Share

  174. KIESSLING F
    US Microbubbles as Smart Sensors of Portal Venous Pressure.
    Radiology. 2021;298:112-113.
    >> Share

  175. HAN K, Kim JH, Yang SG, Park SH, et al
    A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Radiology. 2021;298:212-218.
    >> Share

  176. KANG TW, Jeong WK, Kim YY, Min JH, et al
    Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
    Radiology. 2021;298:82-90.
    >> Share

    November 2020
  177. SOULEN MC, Sofocleous CT
    Achieving Curative Ablation Outcomes: It Is All about the Imaging.
    Radiology. 2020 Nov 10:203930. doi: 10.1148/radiol.2020203930.
    >> Share

    October 2020
  178. FETZER DT
    Recent Advances in US Vascular Imaging: Highlighting an Important Use Case.
    Radiology. 2020 Oct 27:203830. doi: 10.1148/radiol.2020203830.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016